STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
STSA
Delisted
STSA was delisted on the 7th of June, 2023.
52 hedge funds and large institutions have $396M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
+16
Holders Change %
+44.44%
% of All Funds
1.07%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
19
Increased
21
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
BlackRock
New York
|
+$9.71M |
2 |
IC
Ikarian Capital
Dallas,
Texas
|
+$9.46M |
3 |
GTC
Ghost Tree Capital
New York
|
+$6.47M |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.47M |
5 |
State Street
Boston,
Massachusetts
|
+$1.96M |